Home › Funds › Balyasny Asset Management › HIMS
Balyasny Asset Management position in HIMS
HIMS & HERS HEALTH INC · Health Care
Latest position (Q2 2026)432.06K sh
Reported value held$14.98M
Portfolio Weight0.02%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 12.36K | $81.00K | New |
| Q1 2022 | 103.84K | $553.00K | Add |
| Q1 2023 | 1.24M | $12.27M | New |
| Q4 2023 | 361.60K | $3.22M | New |
| Q3 2024 | 1.78M | $32.79M | New |
| Q4 2024 | 118.44K | $2.86M | Reduce |
| Q1 2025 | 277.20K | $8.19M | Add |
| Q2 2025 | 237.50K | $11.84M | Reduce |
| Q3 2025 | 208.00K | $11.80M | Reduce |
| Q4 2025 | 146.40K | $4.75M | Reduce |
| Q1 2026 | 144.80K | $3.01M | Reduce |
| Q2 2026 | 432.06K | $14.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding HIMS
- BlackRock Inc 28.70M sh · $995.15M · Q2 2026
- Vanguard Group 20.93M sh · $679.46M · Q4 2025
- Citadel Advisors 10.04M sh · $348.06M · Q2 2026
- Goldman Sachs Group 8.42M sh · $291.75M · Q2 2026
- Morgan Stanley 7.15M sh · $247.98M · Q2 2026
- Geode Capital Management 5.68M sh · $197.02M · Q2 2026
- D. E. Shaw & Co 5.17M sh · $179.38M · Q2 2026
- Fidelity Management & Research (FMR) 4.32M sh · $149.89M · Q2 2026
- Marshall Wace 4.22M sh · $146.23M · Q2 2026
- UBS Group AG 2.92M sh · $101.22M · Q2 2026
- Northern Trust Corp 2.59M sh · $89.94M · Q2 2026
- Charles Schwab Investment Management 2.45M sh · $85.07M · Q2 2026